Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
IL-23
55 Products
55 Products
146 Diseases
16562 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
24
48
72
96
120
144
168
192
216
240
Stelara
(ustekinumab) / J&J
Tremfya
(guselkumab) / J&J
Skyrizi
(risankizumab-rzaa) / AbbVie, Boehringer Ingelheim
Ilumya
(tildrakizumab-asmn) / Sun Pharma, Almirall
Omvoh
(mirikizumab) / Eli Lilly
JNJ-2113
/ J&J
Ozespa
(briakinumab) / AbbVie
brazikumab
(AMG 139) / AstraZeneca
apilimod
(STA-5326) / Madrigal Pharma
VB-201
/ VBL Therap
golimumab/guselkumab
(JNJ-4804) / J&J
picankibart
(IBI112) / Innovent Biologics
ebdarokimab
(AK101) / Akesobio
BAT2206
(ustekinumab biosimilar) / Bio-Thera Solutions, Pharmapark, Hikma, Biomm
VTX958
/ Ventyx Biosci
apilimod dimesylate
(AIT-101) / OrphAI Therap
CT-P43
(ustekinumab biosimilar) / Celltrion, Hikma
PTG-200
/ J&J
Pyzchiva
(ustekinumab biosimilar) / Samsung, Sandoz
QX004N
/ Qyuns Therap
Uzpruvo
(ustekinumab biosimilar) / Alvotech, Fuji Pharma, Cipla, Teva, Stada
Bmab1200
(ustekinumab biosimilar) / Biocon, Yoshindo
FYB202
(ustekinumab biosimilar) / Formycon, Fresenius Kabi
PN-232
/ J&J
Wezlana
(ustekinumab-auub) / Amgen
mRNA-2752
/ Moderna
AN2898
/ Pfizer
BFI-751
(ustekinumab biosimilar) / BioFactura, Aurobindo
DMB-3115
(ustekinumab biosimilar) / Dong-A, Intas, Meiji Seika
LY2525623
/ Eli Lilly
NBL-012
/ CSPC Pharma
NeuLara
(ustekinumab biosimilar) / NeuClone, Serum Institute of India
PF-07261271
/ Pfizer
RT-111
(ustekinumab biosimilar) / Rani Therap, Celltrion
SFA-002
/ SFA Therap
SOR102
/ Sorriso Pharma